# Ainnovi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ainnovi

- Industry: Medical Devices & Equipment
- Headquarters: Jiaxing, China
- Website: www.ainnovi.com/
- Total disclosed funding: $14M
- Latest round: Series A (Aug 18, 2025)
- Investors on record: 5

## About

Founded in 2020 and based in Jiaxing, China, Ainnovi is a medical technology company that focuses on developing computational imaging technology. In August 2025, Ainnovi closed a series A+ funding from new investor Lotus Lake Capital. The company's main products include 4K3D ultra-high-definition screen-based surgery system, 4K ultra-high-definition fluorescence microscopy system and complete solutions for screen-based surgery. Its products are used in the fields of neurosurgery, otolaryngology, ophthalmology, spinal surgery, etc. The company’s revenue is generated by providing intelligent microscopic medical robot system. The company will use the series A funding for the research and development, registration and marketing of surgical and ophthalmic modular products and complete microsurgical exoscopes.

## Funding rounds

- Series A, Aug 18, 2025 — Lotus Lake Capital
- Series A, Dec 16, 2024, $14M — Sunland Capital, Tsingstone Capital, Lingyi Capital, Chongqing Airuiling

## Investors

- Sunland Capital — Series A
- Tsingstone Capital (https://capitalatlas.ai/funds/tsingstone-capital) — Series A
- Lingyi Capital (https://capitalatlas.ai/funds/lingyi-capital) — Series A
- Chongqing Airuiling — Series A
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A